It has been reported that UC-MSC can inhibit TGF-β1 expression in the kidney tissue of the diabetic nephropathy mice model and inhibit its downstream PI3K/Akt and MAPK signaling pathways (Li et al., 2020). This evidence concerns the gene TGFB1 and diabetic kidney disease.